These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 5125055

  • 1. [On the treatment of Parkinson's disease with intravenous administration of amantadine (77 cases)].
    Fasano VA, Urciuoli R, Broggi G.
    Minerva Med; 1971 Oct 31; 62(82):3968-70. PubMed ID: 5125055
    [No Abstract] [Full Text] [Related]

  • 2. [Intravenous and oral treatment with amantadine sulfate in Parkinson disease].
    Brenner M, Haass A, Jacobi P, Schimrigk K.
    Nervenarzt; 1988 Mar 31; 59(3):180-4. PubMed ID: 3374720
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F, Grünberger J, Oberhummer I.
    Wien Med Wochenschr; 1971 May 08; 121(19):390-7. PubMed ID: 5559920
    [No Abstract] [Full Text] [Related]

  • 6. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F, Grünberger J, Oberhummer I.
    HNO; 1970 Nov 08; 18(11):390-7. PubMed ID: 5512006
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D, Friedman A.
    Mov Disord; 2007 May 15; 22(7):1033-6. PubMed ID: 17370308
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amantadine hydrochloride in the treatment of Parkinson's disease.
    Nagaswami S, Ranjini R.
    J Kans Med Soc; 1971 Nov 15; 72(11):465-8. PubMed ID: 5120698
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of Parkinson's syndrome with L-dopa associated with diphenhydramine hydrochloride and amantadine hydrochloride].
    Scotti G.
    Sist Nerv; 1970 Nov 15; 22(2):144-52. PubMed ID: 5504553
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Amantadine treatment in parkinsonism].
    Holmsen R.
    Tidsskr Nor Laegeforen; 1973 Oct 10; 93(28):2118-9. PubMed ID: 4773984
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined treatment in Parkinson's disease.
    Wheatley D.
    Practitioner; 1983 Mar 10; 227(1377):446-7. PubMed ID: 6889232
    [No Abstract] [Full Text] [Related]

  • 16. Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
    Deutschländer A, Asmus F, Marelli E, Klopstock T, Gasser T, Bötzel K.
    Mov Disord; 2006 Sep 10; 21(9):1523-5. PubMed ID: 16755578
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amantadine in Parkinson's disease: pro and contra.
    Greulich W, Fenger E.
    J Neural Transm Suppl; 1995 Sep 10; 46():415-21. PubMed ID: 8821077
    [Abstract] [Full Text] [Related]

  • 20. [Clinical effects of L-dopa in Parkinson's disease].
    Fasano VA.
    Sist Nerv; 1970 Sep 10; 22(2):119-23. PubMed ID: 5504550
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.